NCT03015961 - Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions

Postoperative Pain Management

Interventions

DRUG

EXPAREL and bupivacaine HCl

"Drug: EXPAREL EXPAREL and bupivacaine HCl~Other Name: bupivacaine liposome injectable suspension Drug: Bupivacaine Single dose of bupivacaine HCl 0.5%~Other Name: bupivacaine HCl"

DRUG

Bupivacaine HCl

"Drug: Bupivacaine Single dose of bupivacaine HCl 0.5%~Other Name: bupivacaine HCl"

Trial Locations (15)

10029

Icahn School of Medicine, New York

19107

Thomas Jefferson University of Neurosurgery, Philadelphia

22903

Univ of Virginia, Charlottesville

23834

Colonial Orthopaedics, Colonial Heights

26506

West Virginia University Hospitals, Morgantown

28207

OrthoCarolina, Charlotte

43210

Ohio State Univ, Columbus

48085

Beaumont Health, Troy

63110

Washington Univ, St Louis

76508

Baylor Scott & White, Temple

78731

Central Texas Spine Institute, Austin

85013

St. Joseph's Hospital, Phoenix

85295

OrthoArizona, Gilbert

95817

UC Davis, Sacramento

02114

Massachusetts General Hospital, Boston